Angiotensin II Type 2 Receptor: A Novel Modulator of Inflammation in Pancreatic Ductal Adenocarcinoma through Regulation of NF-ΚB Activity

Journal Title: Journal of Cancer and Tumor International - Year 2017, Vol 5, Issue 1

Abstract

Aims: The aim of this study was to explore potential pro-inflammatory, pro-migratory and pro-invasive roles of angiotensin II type 2 receptor (AT2R) in pancreatic ductal adenocarcinoma (PDAC) cells. Study Design: AT2R-specific agonist (CGP42112A, CGP), blocking antibody, or siRNA were interchangeably used to analyze functional impact of AT2R on PDAC cell proliferation, migration, and invasion. Results: This study revealed that AT2R blockade reduced proliferation, migration and invasion of PDAC cells. Blocking AT2R significantly lowed the expression of oxidative-stress genes Nox1, Nox3, Nox4, and Nox5, and pro-invasive genes MMP-2, MMP-9, OPN, and α5-integrin. AT2R siRNA significantly downregulated the expression levels of pro-inflammatory IL-1beta, IFN-γ, iNOS, IL-6, IL-8, and IL-15 mRNA. Blocking AT2R also inhibited the intrinsic and angiotensin II (AngII) or CGP-mediated activation of NF-κB. Conclusion: These findings demonstrate previously unknown pro-inflammatory, pro-migratory and pro-invasive effects of AT2R in PDAC cells. Our data suggest that one mechanism by which AT2R promote inflammation is through activation of constitutive and AngII-mediated NF-κB. Thus, AT2R blockade could be a novel therapeutic strategy to target multiple pathways that mediate PDAC carcinogenesis.

Authors and Affiliations

Ankit V. Gandhi, Galina Chipitsyna, Daniel Relles, Charles J. Yeo, Hwyda A. Arafat

Keywords

Related Articles

A Rare Case Report of a Metastatic Tumor of the Spermatic Cord Arising from Pancreatic Cancer

A 60-year-old patient complaining of pain and elevation of the right scrotal contents, who had been treated for pancreatic cancer, was suspected of having spermatic cord tumor. He underwent high orchiectomy for pain mana...

Combined Intralipid-urotherapy for Patients with Cancer: A Creative Review

The article relates in general to intralipid and its use in cancer therapy. Specifically, it relates to the combined intralipid-urotherapy for treating cancer, and methods of such treatment. Cancer cells release various...

Immunohistochemical Pattern of Breast Cancer in Maiduguri, Borno State

Background: Breast cancer is one of the most common cancer affecting women in Nigeria, with a very high morbidity and mortality rate if the diagnosis is delayed. It is common among women in both developed and developing...

Evaluation of Cardiac Biomarkers in Detection of Cardiomyopathy Induced by Cardiotoxic Chemotherapeutic Agents

Background: Doxorubicin is a potent chemotherapeutic drug. The clinical usefulness of doxorubicin has been limited largely by the risk of cardiomyopathy and life-threatening heart failure. Therefore early identification...

Gallbladder Carcinoma in Ghana: Histopathological Examination of Cholecystectomy Specimen

Objective: The aim of the study was to find out the incidence of gallbladder carcinoma in cholecystectomy specimen and the histological types from Korle-Bu Teaching Hospital, Ghana. Methods: The study was a retrospective...

Download PDF file
  • EP ID EP308889
  • DOI 10.9734/JCTI/2017/31326
  • Views 98
  • Downloads 0

How To Cite

Ankit V. Gandhi, Galina Chipitsyna, Daniel Relles, Charles J. Yeo, Hwyda A. Arafat (2017). Angiotensin II Type 2 Receptor: A Novel Modulator of Inflammation in Pancreatic Ductal Adenocarcinoma through Regulation of NF-ΚB Activity. Journal of Cancer and Tumor International, 5(1), 1-11. https://europub.co.uk./articles/-A-308889